注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Cardiff Oncology Inc是一家臨床階段生物技術公司。該公司專注於為癌症患者開發治療方案。其候選藥物onvansertib是一種polo樣激酶1(PLK1)三磷酸腺苷(ATP)競爭性抑製劑,結合化療和靶向治療。其臨床試驗包括TROV-054、CRDF-001和TROV-053。TROV-054是onvansertib聯合FOLFIRI(葉酸、氟尿嘧啶和irinotecan)和Avastin(bevacizumab)的I期b/2開放標籤臨床試驗。TROV-053是onvansertib聯合Zytiga(abiraterone acetate)/強的鬆的II期開放標籤臨床試驗。CRDF-001是onvansertib聯合納米脂質體irinotecan、亞葉酸和氟尿嘧啶治療轉移性胰腺導管腺癌(mPDAC)患者的2期開放標籤多中心臨床試驗。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Sandra L. Silberman | 65 | 2017 | Member of Clinical Advisory Board |
Filip Janku | 47 | - | Member of Clinical Advisory Board |
Emmanuel Antonarakis | - | 2020 | Member of Clinical Advisory Board |
Mark Erlander | 61 | 2013 | CEO & Director |
Rodney S. Markin | 64 | 2014 | Independent Chairman of the Board |
Gary W. Pace | 73 | 2020 | Independent Director |
Renee P. Tannenbaum | 70 | 2021 | Independent Director |
Lale White | 66 | 2020 | Independent Director |
Carlo Maria Croce | - | - | Member of Scientific Advisory Board |
Paul R. Billings | 70 | 2012 | Member of Scientific Advisory Board |
Charles R. Cantor | 79 | - | Member of Scientific Advisory Board |
Michael B. Yaffe | - | 2018 | Member of Clinical Advisory Board |
Glenn J. Bubley | - | 2018 | Member of Clinical Advisory Board |
Heinz-Josef Lenz | 62 | 2020 | Member of Clinical Advisory Board |
Alberto Bardelli | - | 2014 | Member of Scientific Advisory Board |
Brunangelo Falini | - | 2010 | Member of Scientific Advisory Board |
K. Peter Hirth | 70 | 2014 | Member of Scientific Advisory Board |
James O. Armitage | 75 | 2020 | Independent Director |
Mani Mohindru | 50 | 2021 | Independent Director |
Amer Zeidan | - | 2020 | Member of Clinical Advisory Board |
Riccardo Dalla-Favera | 70 | 2010 | Member of Scientific Advisory Board |
David Einstein | - | 2018 | Member of Clinical Advisory Board |
Eric Van-Cutsem | - | - | Member of Scientific Advisory Board |
Adam Schayowitz | - | - | Member of Scientific Advisory Board |
Christoph Reinhard | - | - | Member of Scientific Advisory Board |
Josep Tabernero | - | - | Member of Scientific Advisory Board |
Scott Kopetz | - | - | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核